Ascentage Pharma brings positive news on chronic hepatitis B drug

Ascentage Pharma brings positive news on chronic hepatitis B drug

Ascentage Pharma has published the results of a phase I study of the investigational apoptosis protein (IAP) antagonist APG-1387 in Chinese patients with chronic hepatitis B (CHB). The results were presented at the 73rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2022). This is the first clinical trial in …

Ascentage Pharma brings positive news on chronic hepatitis B drug Read More »